Updated: Pfizer triumphs over Novo Nordisk with $10B bid for Metseranews2025-11-08T09:36:54+00:00November 8th, 2025|Endpoints News|
Zuckerberg-backed Biohub hires EvolutionaryScale team in apparent end of AI startupnews2025-11-07T00:06:20+00:00November 7th, 2025|Endpoints News|
Novo Nordisk raises Metsera bid again, hoping to top Pfizer’s latest offernews2025-11-06T15:56:47+00:00November 6th, 2025|Endpoints News|
FTC raises concerns about structure of Novo Nordisk’s bid for Metseranews2025-11-05T19:49:59+00:00November 5th, 2025|Endpoints News|
‘Everybody’s talking about it’: Metsera bidding war grips the obesity fieldnews2025-11-05T10:00:02+00:00November 5th, 2025|Endpoints News|
Updated: Novo ups Metsera bid to as much as $10B in attempt to top Pfizer’s new offernews2025-11-04T14:44:43+00:00November 4th, 2025|Endpoints News|
Swiss biotech CDR-Life returns to Boehringer Ingelheim to partner on autoimmune T cell engagernews2025-11-04T13:00:32+00:00November 4th, 2025|Endpoints News|
Blackstone to pay Merck $700M to fund development of antibody-drug conjugatenews2025-11-04T12:29:04+00:00November 4th, 2025|Endpoints News|
South Korean biotech sets up California startup to advance ADCsnews2025-11-04T12:00:25+00:00November 4th, 2025|Endpoints News|
Post-Hoc Live: M&A, FDA, MFN and more — with our cousins at the FTnews2025-11-04T12:00:13+00:00November 4th, 2025|Endpoints News|
